Labisto, Roy A.

HRN: 27-36-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/30/2026
04/05/2026
IV
2.25g
Q6h
Septic Arthritis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines